Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies

By C. Köhler, T. H. Freitas, M. Maes, N. Q. de Andrade, C. Liu, Brisa Fernandes, Brendon Stubbs, M. Solmi, N. Veronese, N. Herrmann and 4 more. Acta Psychiatrica Scandinavica, 2017

1,290 citations recorded by the source corpus.

Subfields: Behavioral Neuroscience, Biological Psychiatry, General Health Professions

View Paper: https://www.semanticscholar.org/paper/c8ba0132ef96678f0e0a3d8e5530a8249cd924a3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Behavioral Neuroscience

1. C. Nemeroff
2. Eléonore Beurel
3. M. Toups

In Biological Psychiatry

1. C. Nemeroff
2. Eléonore Beurel
3. M. Toups

Citations in the corpus

• Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. (2018, neutral): “The evidence on immune biomarkers in depression has been synthesized in a number of meta-analyses (Dowlati et al., 2010; Haapakoski et al., 2015; Howren et al., 2009; Köhler et al., 2017).”
• Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors (2020, positive): “Cytokines dysregulation (especially IL-1β, IL-6, IL-10, IFN-γ, TNF-α, and transforming growth factor-β (TGF-β)) are known to involve factors that others and we associated with psychiatric disorders (Kohler et al., 2017; Miller et al., 2011; Renna et al., 2018; Poletti et al., 2019; Benedetti et al.,”
• Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls (2020, neutral): “2 shows that there was significantly lower CVR in patients using for IL-12; IL-13; sIL-2R; CRP; and IFNγ.”
• The Bidirectional Relationship of Depression and Inflammation: Double Trouble (2020, background): “It is important to note that the levels of anti-inflammatory cytokines, including transforming growth factor (TGF)-β and IL-10, are also often elevated in MDD patients, raising the question of their role in depression (Dowlati et al., 2010; Howren et al., 2009; Köhler et al., 2017) and their potenti”